D
Aspen Aerogels, Inc.
ASPN
$7.95
$0.151.92%
D
Sell
3/3/2025Upgraded
Aspen Aerogels, Inc. (ASPN) was upgraded to D+ from D on 3/3/2025 due to a major increase in the growth index, valuation index and solvency index. Earnings per share increased from -$0.1701 to $0.1359, operating cash flow increased 71.8% from $20.77M to $35.68M, and the quick ratio increased from 2.19 to 3.
Aspen Aerogels, Inc. (ASPN) was upgraded to D+ from D on 3/3/2025 due to a major increase in the growth index, valuation index and solvency index. Earnings per share increased from -$0.1701 to $0.1359, operating cash flow increased 71.8% from $20.77M to $35.68M, and the quick ratio increased from 2.19 to 3.
D
Sell
11/8/2024Downgrade
Aspen Aerogels, Inc. (ASPN) was downgraded to D from C- on 11/8/2024 due to a significant decline in the growth index, solvency index and total return index. Earnings per share declined from $0.21 to -$0.1701, debt to equity increased from 0.24 to 0.33, and EBIT declined 12.94% from $19.99M to $17.4M.
Aspen Aerogels, Inc. (ASPN) was downgraded to D from C- on 11/8/2024 due to a significant decline in the growth index, solvency index and total return index. Earnings per share declined from $0.21 to -$0.1701, debt to equity increased from 0.24 to 0.33, and EBIT declined 12.94% from $19.99M to $17.4M.
C
Hold
8/15/2024Upgraded
Aspen Aerogels, Inc. (ASPN) was upgraded to C- from D- on 8/15/2024 due to a significant increase in the growth index, efficiency index and total return index. Net income increased 1,016.51% from -$1.84M to $16.82M, earnings per share increased from -$0.0242 to $0.21, and operating cash flow increased 138.55% from -$17.75M to $6.84M.
Aspen Aerogels, Inc. (ASPN) was upgraded to C- from D- on 8/15/2024 due to a significant increase in the growth index, efficiency index and total return index. Net income increased 1,016.51% from -$1.84M to $16.82M, earnings per share increased from -$0.0242 to $0.21, and operating cash flow increased 138.55% from -$17.75M to $6.84M.
D
Sell
7/26/2023Upgraded
Aspen Aerogels, Inc. (ASPN) was upgraded to D- from E+ on 7/26/2023 due to an increase in the volatility index.
Aspen Aerogels, Inc. (ASPN) was upgraded to D- from E+ on 7/26/2023 due to an increase in the volatility index.
E
Sell
5/17/2023Downgrade
Aspen Aerogels, Inc. (ASPN) was downgraded to E+ from D- on 5/17/2023 due to a decline in the volatility index, total return index and valuation index.
Aspen Aerogels, Inc. (ASPN) was downgraded to E+ from D- on 5/17/2023 due to a decline in the volatility index, total return index and valuation index.
D
Sell
3/14/2023Downgrade
Aspen Aerogels, Inc. (ASPN) was downgraded to D- from D on 3/14/2023 due to a decline in the total return index.
Aspen Aerogels, Inc. (ASPN) was downgraded to D- from D on 3/14/2023 due to a decline in the total return index.
D
Sell
2/23/2023Upgraded
Aspen Aerogels, Inc. (ASPN) was upgraded to D from D- on 02/23/2023.
Aspen Aerogels, Inc. (ASPN) was upgraded to D from D- on 02/23/2023.
D
Sell
2/8/2023Downgrade
Aspen Aerogels, Inc. (ASPN) was downgraded to D- from D on 2/8/2023 due to a large decline in the total return index, solvency index and volatility index. The quick ratio declined from 2.69 to 1.6.
Aspen Aerogels, Inc. (ASPN) was downgraded to D- from D on 2/8/2023 due to a large decline in the total return index, solvency index and volatility index. The quick ratio declined from 2.69 to 1.6.
D
Sell
5/31/2022Upgraded
Aspen Aerogels, Inc. (ASPN) was upgraded to D from D- on 5/31/2022 due to an increase in the valuation index.
Aspen Aerogels, Inc. (ASPN) was upgraded to D from D- on 5/31/2022 due to an increase in the valuation index.
D
Sell
5/13/2022Downgrade
Aspen Aerogels, Inc. (ASPN) was downgraded to D- from D on 5/13/2022 due to a noticeable decline in the solvency index and volatility index. Debt to equity increased from 0.02 to 0.57.
Aspen Aerogels, Inc. (ASPN) was downgraded to D- from D on 5/13/2022 due to a noticeable decline in the solvency index and volatility index. Debt to equity increased from 0.02 to 0.57.
D
Sell
5/5/2022Upgraded
Aspen Aerogels, Inc. (ASPN) was upgraded to D from D- on 5/5/2022 due to an increase in the valuation index.
Aspen Aerogels, Inc. (ASPN) was upgraded to D from D- on 5/5/2022 due to an increase in the valuation index.
D
Sell
4/20/2022Downgrade
Aspen Aerogels, Inc. (ASPN) was downgraded to D- from D on 4/20/2022 due to a significant decline in the total return index and volatility index.
Aspen Aerogels, Inc. (ASPN) was downgraded to D- from D on 4/20/2022 due to a significant decline in the total return index and volatility index.
D
Sell
11/23/2021Upgraded
Aspen Aerogels, Inc. (ASPN) was upgraded to D from D- on 11/23/2021 due to an increase in the total return index and volatility index.
Aspen Aerogels, Inc. (ASPN) was upgraded to D from D- on 11/23/2021 due to an increase in the total return index and volatility index.
D
Sell
11/8/2021Downgrade
Aspen Aerogels, Inc. (ASPN) was downgraded to D- from D on 11/8/2021 due to a large decline in the growth index and valuation index. Operating cash flow declined 550.48% from $1.34M to -$6.05M, EBIT declined 73.84% from -$6.61M to -$11.5M, and total revenue declined 4.07% from $31.67M to $30.38M.
Aspen Aerogels, Inc. (ASPN) was downgraded to D- from D on 11/8/2021 due to a large decline in the growth index and valuation index. Operating cash flow declined 550.48% from $1.34M to -$6.05M, EBIT declined 73.84% from -$6.61M to -$11.5M, and total revenue declined 4.07% from $31.67M to $30.38M.
D
Sell
9/10/2020Downgrade
Aspen Aerogels, Inc. (ASPN) was downgraded to D from D+ on 9/10/2020 due to a decline in the valuation index.
Aspen Aerogels, Inc. (ASPN) was downgraded to D from D+ on 9/10/2020 due to a decline in the valuation index.
D
Sell
8/6/2020Upgraded
Aspen Aerogels, Inc. (ASPN) was upgraded to D+ from D on 8/6/2020 due to a noticeable increase in the growth index and solvency index. The quick ratio increased from 1.77 to 2.44.
Aspen Aerogels, Inc. (ASPN) was upgraded to D+ from D on 8/6/2020 due to a noticeable increase in the growth index and solvency index. The quick ratio increased from 1.77 to 2.44.
D
Sell
5/20/2020Downgrade
Aspen Aerogels, Inc. (ASPN) was downgraded to D from D+ on 5/20/2020 due to a substantial decline in the growth index, efficiency index and total return index. EBIT declined 271.81% from -$830 to -$3.09M, net income declined 231.49% from -$956 to -$3.17M, and earnings per share declined from -$0.0395 to -$0.1258.
Aspen Aerogels, Inc. (ASPN) was downgraded to D from D+ on 5/20/2020 due to a substantial decline in the growth index, efficiency index and total return index. EBIT declined 271.81% from -$830 to -$3.09M, net income declined 231.49% from -$956 to -$3.17M, and earnings per share declined from -$0.0395 to -$0.1258.
D
Sell
4/27/2020Downgrade
Aspen Aerogels, Inc. (ASPN) was downgraded to D+ from C- on 4/27/2020 due to a significant decline in the total return index, solvency index and volatility index.
Aspen Aerogels, Inc. (ASPN) was downgraded to D+ from C- on 4/27/2020 due to a significant decline in the total return index, solvency index and volatility index.
C
Hold
3/6/2020Upgraded
Aspen Aerogels, Inc. (ASPN) was upgraded to C- from D on 3/6/2020 due to a significant increase in the total return index, growth index and efficiency index. Operating cash flow increased 223.28% from -$3.82M to $4.71M, EBIT increased 61.45% from -$2.15M to -$830, and earnings per share increased from -$0.0947 to -$0.0395.
Aspen Aerogels, Inc. (ASPN) was upgraded to C- from D on 3/6/2020 due to a significant increase in the total return index, growth index and efficiency index. Operating cash flow increased 223.28% from -$3.82M to $4.71M, EBIT increased 61.45% from -$2.15M to -$830, and earnings per share increased from -$0.0947 to -$0.0395.
D
Sell
5/15/2019Upgraded
Aspen Aerogels, Inc. (ASPN) was upgraded to D from D- on 5/15/2019 due to an increase in the volatility index and total return index.
Aspen Aerogels, Inc. (ASPN) was upgraded to D from D- on 5/15/2019 due to an increase in the volatility index and total return index.
D
Sell
3/12/2019Downgrade
Aspen Aerogels, Inc. (ASPN) was downgraded to D- from D on 3/12/2019 due to a decline in the efficiency index, solvency index and total return index. Net income declined 115.98% from -$6.53M to -$14.11M, total capital declined 16.03% from $88.65M to $74.44M, and the quick ratio declined from 1.37 to 1.25.
Aspen Aerogels, Inc. (ASPN) was downgraded to D- from D on 3/12/2019 due to a decline in the efficiency index, solvency index and total return index. Net income declined 115.98% from -$6.53M to -$14.11M, total capital declined 16.03% from $88.65M to $74.44M, and the quick ratio declined from 1.37 to 1.25.
D
Sell
7/7/2017Upgraded
Aspen Aerogels, Inc. (ASPN) was upgraded to D from D- on 7/7/2017 due to an increase in the total return index.
Aspen Aerogels, Inc. (ASPN) was upgraded to D from D- on 7/7/2017 due to an increase in the total return index.
D
Sell
5/17/2017Downgrade
Aspen Aerogels, Inc. (ASPN) was downgraded to D- from D on 5/17/2017 due to a noticeable decline in the growth index and solvency index. Operating cash flow declined 660.79% from $788 to -$4.42M, EBIT declined 58.53% from -$5.71M to -$9.05M, and earnings per share declined from -$0.2495 to -$0.3903.
Aspen Aerogels, Inc. (ASPN) was downgraded to D- from D on 5/17/2017 due to a noticeable decline in the growth index and solvency index. Operating cash flow declined 660.79% from $788 to -$4.42M, EBIT declined 58.53% from -$5.71M to -$9.05M, and earnings per share declined from -$0.2495 to -$0.3903.
D
Sell
7/19/2016Upgraded
Aspen Aerogels, Inc. (ASPN) was upgraded to D from D- on 7/19/2016 due to an increase in the total return index and volatility index.
Aspen Aerogels, Inc. (ASPN) was upgraded to D from D- on 7/19/2016 due to an increase in the total return index and volatility index.
D
Sell
5/11/2016Downgrade
Aspen Aerogels, Inc. (ASPN) was downgraded to D- from D on 5/11/2016 due to a substantial decline in the growth index, efficiency index and volatility index. Earnings per share declined from $0.0701 to -$0.08, net income declined 209.71% from $1.64M to -$1.8M, and EBIT declined 204.39% from $1.68M to -$1.76M.
Aspen Aerogels, Inc. (ASPN) was downgraded to D- from D on 5/11/2016 due to a substantial decline in the growth index, efficiency index and volatility index. Earnings per share declined from $0.0701 to -$0.08, net income declined 209.71% from $1.64M to -$1.8M, and EBIT declined 204.39% from $1.68M to -$1.76M.
D
Sell
3/11/2016Downgrade
Aspen Aerogels, Inc. (ASPN) was downgraded to D from D+ on 3/11/2016 due to a large decline in the volatility index, total return index and valuation index.
Aspen Aerogels, Inc. (ASPN) was downgraded to D from D+ on 3/11/2016 due to a large decline in the volatility index, total return index and valuation index.
D
Sell
1/4/2016Upgraded
Aspen Aerogels, Inc. (ASPN) was upgraded to D+ from D on 1/4/2016 due to a major increase in the growth index, efficiency index and total return index. Total revenue increased 4.79% from $30.1M to $31.54M.
Aspen Aerogels, Inc. (ASPN) was upgraded to D+ from D on 1/4/2016 due to a major increase in the growth index, efficiency index and total return index. Total revenue increased 4.79% from $30.1M to $31.54M.
D
Sell
7/1/2015Upgraded
Aspen Aerogels, Inc. (ASPN) was upgraded to D from D- on 07/01/2015.
Aspen Aerogels, Inc. (ASPN) was upgraded to D from D- on 07/01/2015.
D
Sell
3/2/2015Upgraded
Aspen Aerogels, Inc. (ASPN) was upgraded to D- from E+ on 03/02/2015.
Aspen Aerogels, Inc. (ASPN) was upgraded to D- from E+ on 03/02/2015.
E
Sell
12/1/2014Upgraded
Aspen Aerogels, Inc. (ASPN) was upgraded to E+ from E on 12/1/2014 due to an increase in the total return index and growth index.
Aspen Aerogels, Inc. (ASPN) was upgraded to E+ from E on 12/1/2014 due to an increase in the total return index and growth index.
E
Sell
9/8/2014None
Aspen Aerogels, Inc. (ASPN) was downgraded to E from U on 09/08/2014.
Aspen Aerogels, Inc. (ASPN) was downgraded to E from U on 09/08/2014.
NYSE
03/07/2025 4:00PM Eastern
Quotes delayed
